Valesca Retèl

Erasmus University Rotterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Research Cancer Research professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Manuela Joore

University of Maastricht

NETHERLANDS

View details

Gerrit Meijer

Professor of Oncologic Pathology

University Medical Center Groningen

NETHERLANDS

View details

V.M.T de Jong

The Netherlands Cancer Institute

NETHERLANDS

View details

Melanie Lindenberg

University of Twente

NETHERLANDS

View details

Shaun Treweek

University of Aberdeen

UNITED KINGDOM

View details

Joachim G. Aerts

NETHERLANDS

View details

Özcan Met

Københavns Universitet

DENMARK

View details

Terry Hyslop

Professor, Director of SKCC Center for Health Equity

Thomas Jefferson University

UNITED STATES

View details

Bram Ramaekers

Maastricht University Medical Centre

NETHERLANDS

View details

Winette van der Graaf

Professor

The Netherlands Cancer Institute

NETHERLANDS

View details

Remond J.A. Fijneman

University Medical Center Groningen

NETHERLANDS

View details

Renske ten Ham

Assistant Professor

UMC Utrecht

NETHERLANDS

View details

Inge Marie Svane

Københavns Universitet

DENMARK

View details

Ed Schuuring

University Medical Center Groningen

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Valesca Retèl

Research Interests

Explore related searches

Contact this professor

Articles (30)

Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors

Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial

Financial toxicity and socioeconomic impact of cancer in Europe

Defining the role of pragmatic clinical trials in cancer clinical research

Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology

“One more chance to survive”

Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers

Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer

EBCC-14 manifesto

Preferences and considerations for interval cytoreductive surgery in advanced ovarian cancer

Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design

Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy

The socioeconomic impact of cancer on patients and their relatives

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial

Differences in time to patient access to innovative cancer medicines in six European countries

An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ

Relevant factors for policy concerning comprehensive genomic profiling in oncology

Duty to recontact in genomic cancer care

Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ

Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer

Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer

Collaborators (14)

Manuela Joore

Gerrit Meijer

V.M.T de Jong

Melanie Lindenberg

Shaun Treweek

Joachim G. Aerts

Özcan Met

Terry Hyslop

Bram Ramaekers

Winette van der Graaf

Remond J.A. Fijneman

Renske ten Ham

Inge Marie Svane

Ed Schuuring

Make your next move.